Post by Alira Health

We are excited to engage innovators at the forefront of nuclear medicine and molecular imaging at the 2026 SNMMI Annual Meeting. Nuclear medicine is undergoing a structural shift from a niche, diagnostic-driven field to a core therapeutic modality in precision oncology, driven by the rise of theranostics and alpha-emitting therapies. With this shift, regulatory, supply chain, and market access challenges are emerging that stakeholders must overcome. At Alira Health, our Nuclear Medicine Center of Excellence is dedicated to readying our clients for success in this evolving market and our team is ready to accompany you on this complex development journey.   Don’t miss the chance to connect with our nuclear medicine experts and learn how we can support you with a wide range of services, from manufacturing and logistics to clinical and commercial positioning in the US, EU, and APAC markets. 🔵 Piergiulio Lauriano, Chief Strategy Officer 🔵 Akash N Karopadi, Principal, Management Consulting 🔵 Andrew Moore, Senior Vice President, Commercial